Xtandi 40 MG capsule 120S

Ended Awarded

Contract number
SPE2DR26FFDB6
Awardee
Awarding agency
Obligated
$44,222

Award facts

Contract value 100% obligated
$44,221.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $44,221.60 delivery order to DMS Pharmaceutical Group Inc. on May 28, 2026, for XTANDI 40 mg capsules (120-count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business operating as the sole regional prime vendor under PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract (SPE2DX) with a $499.999 billion ceiling through December 31, 2036. The order carries firm fixed pricing and an ultimate completion date of May 29, 2026. Place of performance is Park Ridge, Illinois.

Quick answers

Who was awarded contract SPE2DR26FFDB6?

SPE2DR26FFDB6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 28, 2026.

How much is contract SPE2DR26FFDB6 worth?

The government has obligated $44,222 on SPE2DR26FFDB6.

Is contract SPE2DR26FFDB6 an order under another contract?

Yes. SPE2DR26FFDB6 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.

Was contract SPE2DR26FFDB6 competed?

The extent of competition for SPE2DR26FFDB6 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login